Home | About | Donate

California Legislature Should Pass Bill Requiring Greater Transparency From Pharmaceutical Companies


#1

California Legislature Should Pass Bill Requiring Greater Transparency From Pharmaceutical Companies

WASHINGTON - Note: This week, the California Legislature is expected to mark up Assembly Bill 463, the “Pharmaceutical Cost Transparency Act of 2015.” AB 463 would require drug manufacturers to file a report with the state of California documenting total costs of research and development, marketing and advertising, and materials and manufacturing for medications with a wholesale cost of more than $10,000 a year, as well as profits attributable to qualifying drugs, among other information.

Our country sorely needs policies to rein in out-of-control pharmaceutical costs.

###